Top 10 at 10: More lithium potential, high grade copper, and ‘Australia’s next rare earths producer’ raises big bucks

Pic: getty
Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.
WINNERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
Code | Company | Price | % | Volume | Market Cap |
---|---|---|---|---|---|
JAV | Javelin Minerals Ltd | 0.0015 | 50% | 1,000,000 | $9,454,152.77 |
MEB | Medibio Limited | 0.002 | 33% | 1,250,000 | $4,980,890.69 |
NRX | Noronex Limited | 0.044 | 26% | 685,341 | $5,966,092.55 |
SGQ | St George Min Ltd | 0.032 | 23% | 5,216,139 | $18,200,463.01 |
ROG | Red Sky Energy. | 0.006 | 20% | 80,944,703 | $26,511,135.99 |
TMS | Tennant Minerals Ltd | 0.048 | 20% | 28,139,790 | $24,663,050.60 |
MCM | Mc Mining Ltd | 0.35 | 17% | 46,739 | $59,296,461.00 |
NAE | New Age Exploration | 0.007 | 17% | 821,864 | $8,615,393.46 |
CTO | Citigold Corp Ltd | 0.008 | 14% | 543,079 | $19,835,613.64 |
SI6 | SI6 Metals Limited | 0.008 | 14% | 98,803 | $10,417,323.55 |
Explorer St George Mining (ASX:SGQ) says there is also “significant lithium potential” at the Mt Alexander nickel-copper-PGE project in WA.
“We will advance the lithium exploration in tandem with drill testing several very promising, recently identified nickel targets announced on 1 September 2022,” SGQ boss John Prineas says.
And Tennant Minerals (ASX:TMS) has hit up to 54.5% copper and 39 g/t gold in latest drilling at the Bluebird discovery in the NT.
LOSERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
Code | Company | Price | % | Volume | Market Cap |
---|---|---|---|---|---|
NSB | Neuroscientific | 0.105 | -51% | 1,336,753 | $30,846,403.25 |
ANL | Amani Gold Ltd | 0.001 | -33% | 2,499,999 | $35,540,161.69 |
LNU | Linius Tech Limited | 0.004 | -20% | 2,000,000 | $11,569,331.56 |
HAS | Hastings Tech Met | 4.4 | -19% | 603,087 | $549,851,547.50 |
AMT | Allegra Orthopaedics | 0.14 | -18% | 178 | $17,758,064.51 |
PRX | Prodigy Gold NL | 0.012 | -14% | 3,008,414 | $8,156,786.48 |
ADR | Adherium Ltd | 0.008 | -11% | 106,777 | $20,049,259.82 |
AUH | Austchina Holdings | 0.008 | -11% | 30,000 | $18,331,494.59 |
NZS | New Zealand Coastal | 0.004 | -11% | 6,634 | $5,071,522.64 |
PNX | PNX Metals Limited | 0.004 | -11% | 2,736,388 | $19,998,260.13 |
The Human Research Ethics Committee (HREC) has rejected NeuroScientific Biopharmaceuticals’ (ASX: NSB) planned Phase I Clinical Trial for EmtinB, a therapeutic peptide initially targeting Alzheimer’s disease and glaucoma.
“Australia’s next rare earths producer” Hastings Technology Metals (ASX:HAS) will raise $110m at a discounted $4.40/share to accelerate development of the Yangibana REE project.
SUBSCRIBE
Get the latest breaking news and stocks straight to your inbox.
It's free. Unsubscribe whenever you want.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.